sharon van isle
Member
Cort, trying to understand all these autoantibody studies. The above study published in Science direct, and others surrounding Rituximab, sounds like a subset of patients have autoantibodies against adrenergic and muscarinic receptors. In 2015 they found increased autoantibodies against adrenergic receptors in people with Pots? This subset had a high chance of going into remission from taking the drug Rituximab. My question for you and anyone else is, since I take a cholinergic blocker Procyclidine to stop muscle spasms and muscle twisting everywhere on my body, would that make me a good candidate to have autoantibodies against these receptors? I also have M.E. Plus, POTS, etc.
http://www.sciencedirect.com/science/article/pii/S0889159115300209
I also have no affiliation with the makers of Procyclidine or Rituximab.
http://www.sciencedirect.com/science/article/pii/S0889159115300209
I also have no affiliation with the makers of Procyclidine or Rituximab.